요로감염 검사 시장 규모, 점유율, 성장 분석 : 검사 키트별, 감염 유형별, 검사 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Urinary Tract Infection Testing Market Size, Share, and Growth Analysis, By Test Kit (Home Test Kits, Laboratory Test Kits), By Infection Type (Urethritis, Cystitis), By Test Type, By End User, By Region - Industry Forecast 2025-2032
상품코드:1663133
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
요로감염 검사 세계 시장 규모는 2023년 6억 1,020만 달러로 평가되었고, 예측 기간(2025-2032년) 동안 4.6%의 연평균 복합 성장률(CAGR)로 2024년 6억 3,827만 달러에서 2032년에는 9억 1,466만 달러로 성장할 것으로 예상됩니다.
세계 요로감염(UTI) 검사 시장은 진단 기술의 발전과 주로 여성에게 많이 발생하는 요로감염에 대한 인식이 높아짐에 따라 성장세를 보이고 있습니다. 주요 촉진요인으로는 요로결석 발병률 증가, 의료비 지출 증가, 요로감염에 취약한 고령화 등이 있습니다. 현장 검사 및 비침습적 방법 등 진단 도구의 혁신으로 요로결석의 조기 발견과 관리가 향상되고 있습니다. 개인 맞춤형 의료 및 예방 의료로의 전환은 첨단 진단 솔루션의 채택을 더욱 촉진하고 있습니다. 그러나 특정 검사 방법의 정확성 및 대체 치료와의 경쟁과 같은 문제는 성장을 저해할 수 있습니다. 전반적으로, 요로결석 검사 시장은 향후 몇 년동안 꾸준히 성장할 것으로 예상되며, 감염 관리의 우선순위가 계속 유지될 것으로 보입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 진보
요로감염 검사 시장 규모 : 검사 키트별 & CAGR(2025-2032년)
시장 개요
가정용 검사 키트
임상용 검사 키트
요로감염 검사 시장 규모 : 감염 유형별&CAGR(2025-2032년)
시장 개요
요도염
방광염
신우신염
요로감염 검사 시장 규모 : 검사 유형별&CAGR(2025-2032년)
시장 개요
소변 검사
소변 배양
감수성 시험
요로감염 검사 시장 규모 : 최종사용자별&CAGR(2025-2032년)
시장 개요
일반 개업의(GP)
비뇨기과의
부인과의
병원 검사실
참조 실험실
병원 구급과
긴급 시술
기타
요로감염 검사 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
전년대비 매출 비교(2022-2024년)
주요 기업 개요
Abbott Laboratories(USA)
Becton, Dickinson and Company(BD)(USA)
bioMerieux SA(France)
Thermo Fisher Scientific Inc.(USA)
Siemens Healthineers AG(Germany)
F. Hoffmann-La Roche Ltd(Switzerland)
Bio-Rad Laboratories, Inc.(USA)
Cepheid(USA)(Parent Company : Danaher Corporation)
Hologic, Inc.(USA)
Quidel Corporation(USA)
Meridian Bioscience, Inc.(USA)
Luminex Corporation(USA)
QIAGEN N.V.(Netherlands)
Beckman Coulter, Inc.(USA)(Parent Company : Danaher Corporation)
Sysmex Corporation(Japan)
OraSure Technologies, Inc.(USA)
GenMark Diagnostics, Inc.(USA)
Mesa Biotech, Inc.(USA)
Alere Inc.(USA)(Parent Company : Abbott Laboratories)
T2 Biosystems, Inc.(USA)
결론과 제안
LSH
영문 목차
영문목차
Global Urinary Tract Infection Testing Market size was valued at USD 610.2 million in 2023 and is poised to grow from USD 638.27 million in 2024 to USD 914.66 million by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).
The global urinary tract infection (UTI) testing market is poised for growth, fueled by advancements in diagnostic technology and increasing awareness of UTIs, which predominantly affect women. Key drivers include a rising incidence of UTIs, elevated healthcare spending, and an aging population more vulnerable to these infections. Innovations in diagnostic tools, such as point-of-care tests and non-invasive methodologies, are improving early detection and management. The shift towards personalized and preventive healthcare further propels the adoption of sophisticated diagnostic solutions. However, challenges like the accuracy of certain testing methods and competition from alternative treatments may temper growth. Overall, as infection management remains a priority in healthcare, the UTI testing market is expected to experience steady expansion in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Urinary Tract Infection Testing Market Segments Analysis
Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Urinary Tract Infection Testing Market
The global urinary tract infection (UTI) testing market is profoundly impacted by the rising incidence of antibiotic-resistant UTIs. The improper utilization and overprescription of antibiotics have resulted in the development of resistant bacterial strains, complicating UTI treatment strategies. This critical issue has heightened the demand for precise diagnostic methods, including urine cultures and susceptibility tests, which aid healthcare professionals in identifying effective treatments based on specific bacteria. Furthermore, the pressing need to address antibiotic resistance has led to increased investment in research for innovative therapies. This ongoing development is driving the market towards advanced solutions aimed at managing resistant UTIs while encouraging responsible antibiotic usage.
Restraints in the Global Urinary Tract Infection Testing Market
Antibiotic resistance is a major challenge impacting the global urinary tract infection (UTI) testing market. The excessive and improper use of antibiotics has resulted in the rise of drug-resistant bacteria, diminishing the effectiveness of standard treatments for UTIs. This issue complicates the management of these infections, leading to longer recovery times, escalating healthcare expenses, and a risk of severe complications for patients. Healthcare professionals must carefully balance the necessity for effective treatment against the prudent use of antibiotics to address this pressing issue. As a result, there is an increasing demand for innovative diagnostic methods and alternative treatment strategies within the UTI market.
Market Trends of the Global Urinary Tract Infection Testing Market
The global urinary tract infection (UTI) testing market is experiencing a significant shift towards Point-of-Care (POC) testing methods, driven by the need for prompt and precise diagnostics. POC tests are increasingly favored due to their ability to deliver rapid results and allow for on-site testing, thus minimizing reliance on centralized laboratories and decreasing turnaround times. This trend caters to rising consumer demands for efficient UTI diagnosis, particularly in primary healthcare environments. As innovations in technology further enhance the accuracy and efficiency of these tests, their integration into routine clinical practice is transforming UTI diagnostics and ultimately improving patient care outcomes worldwide.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2025-2032)
Market Overview
Home Test Kits
Laboratory Test Kits
Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2025-2032)
Market Overview
Urethritis
Cystitis
Pyelonephritis
Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2025-2032)
Market Overview
Urinalysis
Urine Cultures
Susceptibility Testing
Global Urinary Tract Infection Testing Market Size by End User & CAGR (2025-2032)
Market Overview
General Practitioners (GPs)
Urologists
Urogynecologists
Hospital Laboratories
Reference Laboratories
Hospital Emergency Departments
Urgent Care
Others
Global Urinary Tract Infection Testing Market Size & CAGR (2025-2032)
North America (Test Kit, Infection Type, Test Type, End User)
US
Canada
Europe (Test Kit, Infection Type, Test Type, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Test Kit, Infection Type, Test Type, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Test Kit, Infection Type, Test Type, End User)
Brazil
Rest of Latin America
Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
